1. ScholarBank@NUS

Jianbiao Zhou

rp06470

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Jianbiao Zhou
Variants
Zhou J.
Zhou, J.
Zhou, J.B.
Zhou J
Zhou Jianbiao
Zhou, Jianbiao
 
Main Affiliation
 
Faculty
 
Email
csizjb@nus.edu.sg
 

Publications

Results 21-40 of 47 (Search time: 0.009 seconds).

Issue DateTitleAuthor(s)
21May-2013LIN28/LIN28B: An emerging oncogenic driver in cancer stem cellsZhou, J. ; Ng, S.-B.; Chng, W.-J.
221-Mar-2017LIN28B Activation by PRL-3 Promotes Leukemogenesis and a Stem Cell-like Transcriptional Program in AMLZhou, Jianbiao ; Chan, Zit-Liang; Bi, Chonglei; Lu, Xiao; Chong, Phyllis SY ; Chooi, Jing-Yuan ; Cheong, Lip-Lee; Liu, Shaw-Cheng; Ching, Ying Qing ; Zhou, Yafeng; Osato, Motomi; Tan, Tuan Zea ; Ng, Chin Hin ; Ng, Siok-Bian ; Wang, Shi ; Zeng, Qi ; Chng, Wee-Joo 
326-Apr-2018NF-kappa B promotes the stem-like properties of leukemia cells by activation of LIN28BZhou, Jianbiao ; Chooi, Jing-Yuan ; Ching, Ying Qing ; Quah, Jessie Yiying ; Toh, Sabrina Hui-Min ; Ng, Yvonne ; Tan, Tuan Zea ; Chng, Wee-Joo 
428-Feb-2019Non-canonical activation of beta-catenin by PRL-3 phosphatase in acute myeloid leukemiaChong, Phyllis SY ; Zhou, Jianbiao ; Chooi, Jing-Yuan ; Chan, Zit-Liang; Toh, Sabrina Hui Min ; Tan, Tuan Zea ; Wee, Sheena; Gunaratne, Jayantha ; Zeng, Qi ; Chng, Wee-Joo 
524-Sep-2019Novel mechanism of drug resistance to proteasome inhibitors in multiple myeloma.Zhou, Jianbiao ; Chng, Wee-Joo 
6Sep-2013Oncogenic roles of PRL-3 in FLT3-ITD induced acute myeloid leukaemiaPark, J.E.; Yuen, H.F.; Zhou, J.B. ; Al-aidaroos, A.Q.O.; Guo, K.; Valk, P.J.; Zhang, S.D.; Chng, W.J.; Hong, C.W.; Mills, K.; Zeng, Q. 
72009Overexpression of endoplasmic reticulum protein 29 regulates mesenchymal-epithelial transition and suppresses xenograft tumor growth of invasive breast cancer cellsI FON BAMBANG ; Xu, S. ; Salto-Tellez, M. ; Sethi, S.K. ; Zhang, D. ; Zhou, J. 
82015P53 mutations in colorectal cancer- Molecular pathogenesis and pharmacological reactivationLi X.-L; Zhou J ; Chen Z.-R; Chng W.J 
9Nov-2011Pacritinib (SB1518), a JAK2/FLT3 inhibitor for the treatment of acute myeloid leukemiaHart, S.; Goh, K.C.; Novotny-Diermayr, V.; Tan, Y.C.; Madan, B.; Amalini, C.; Ong, L.C.; Kheng, B.; Cheong, A.; Zhou, J. ; Chng, W.J.; Wood, J.M.
1013-Jul-2010PCBP1 Suppresses the Translation of Metastasis-Associated PRL-3 PhosphataseWang, Haihe; Vardy, Leah A; Tan, Cheng Peow; Loo, Jia Min; Guo, Ke; Li, Jie; Lim, Seng Gee ; Zhou, Jianbiao ; Chng, Wee Joo ; Ng, Siok Bian ; Li, Hui Xiang; Zeng, Qi
112015PRIMA-1met (APR-246) inhibits growth of colorectal cancer cells with different p53 status through distinct mechanismsLi, X.-L; Zhou, J ; Chan, Z.-L; Chooi, J.-Y ; Chen, Z.-R; Chng, W.-J 
122011PRL-3, a metastasis associated tyrosine phosphatase, is involved in FLT3-ITD signaling and implicated in anti-aml therapyZhou, J. ; Bi, C.; Chng, W.-J.; Cheong, L.-L.; Liu, S.-C.; Mahara, S. ; Tay, K.-G. ; Zeng, Q.; Li, J.; Guo, K.; Tan, C.P.B.; Yu, H. ; Albert, D.H.; Chen, C.-S.
132019PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoproteinThura M.; Al-Aidaroos A.Q.; Gupta A. ; Chee C.E. ; Lee S.C. ; Hui K.M. ; Li J.; Guan Y.K. ; Yong W.P. ; So J. ; Chng W.J. ; Ng C.H. ; Zhou J. ; Wang L.Z. ; Yuen J.S.P. ; Ho H.S.S. ; Yi S.M.; Chiong E. ; Choo S.P. ; Ngeow J. ; Ng M.C.H. ; Chua C. ; Yeo E.S.A. ; Tan I.B.H. ; Sng J.X.E.; Tan N.Y.Z.; Thiery J.P. ; Goh B.C. ; Zeng Q. 
142-Nov-2021PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein (vol 10, 2484, 2019)Thura, Min; Al-Aidaroos, Abdul Qader; Gupta, Abhishek ; Chee, Cheng Ean ; Lee, Soo Chin ; Hui, Kam Man ; Li, Jie; Guan, Yeoh Khay ; Yong, Wei Peng ; So, Jimmy; Chng, Wee Joo ; Ng, Chin Hin ; Zhou, Jianbiao ; Wang, Ling Zhi; Yuen, John Shyi Peng; Ho, Henry Sun Sien ; Yi, Sim Mei; Chiong, Edmund ; Choo, Su Pin ; Ngeow, Joanne; Ng, Matthew Chau Hsien ; Chua, Clarinda; Yeo, Eugene Shen Ann ; Tan, Iain Bee Huat ; Sng, Joel Xuan En; Tan, Nicholas Yan Zhi; Thiery, Jean Paul ; Goh, Boon Cher ; Zeng, Qi 
15Sep-2010Pulse-modulated second harmonic imaging microscope quantitatively demonstrates marked increase of collagen in tumor after chemotherapyRaja, A.M.; Xu, S.; Sun, W.; Zhou, J. ; Tai, D.C.S.; Chen, C.-S.; Rajapakse, J.C.; So, P.T.C.; Yu, H. 
1616-Jun-2010Reduced plasma APOA1 level is associated with Gastric Tumor Growth in MKN45 mouse xenograft modelChong, P.-K. ; Lee, H. ; Zhou, J. ; Liu, S.-C.; Loh, M.C.S. ; So, J.B.Y.; Lim, K.H.; Yeoh, K.-G.; Lim, Y.-P. 
1714-Sep-2018RESISTANCE TO FLT3 INHIBITORS IN ACUTE MYELOID LEUKEMIA: MOLECULAR MECHANISMS AND RESENSITIZING STRATEGIESZhou, J ; CHNG WEE JOO 
181-Feb-2022Super Enhancer-Mediated Upregulation of HJURP Promotes Growth and Survival of t(4;14)-PositiveJia, Yunlu; Zhou, Jianbiao ; Tan, Tze King ; Chung, Tae-Hoon ; Chen, Yongxia; Chooi, Jing-Yuan ; Sanda, Takaomi ; Fullwood, Melissa J ; Xiong, Sinan; Toh, Sabrina HM ; Balan, Kalpnaa ; Wong, Regina WJ ; Lim, Julia SL ; Zhang, Enfan; Cai, Zhen; Shen, Peng; Chng, Wee Joo 
192019Super-enhancers: Critical roles and therapeutic targets in hematologic malignanciesJia, Y.; Chng, W.-J. ; Zhou, J. 
202007Synergistic antileukemia effect of genistein and chemotherapy in mouse xenograft model and potential mechanism through MAPK signalingShen, J.; Tai, Y.-C. ; Zhou, J. ; Stephen, Wong C.-H. ; Xie, Z. ; Chen, C.-S. ; Cheang, P.T.S. ; Han, J.-H. ; Fred, Wong W.-S. ; Khan, M.